Courtesy Alexandria Real Estate Equities

One of the largest developers of life science space in Cambridge and the U.S., Alexandria Real Estate Equities, is investing directly in its tenants through its Alexandria Seed Capital Platform.

The latest recipient is Cambridge-based researcher Holobiome Inc., which is developing treatments for nervous system disorders. Alexandria said this week it made an undisclosed investment in the firm, which is a tenant in its 20,000-square-foot Alexandria LaunchLabs at Alexandria Center at One Kendall Square in Cambridge. The six-month-old incubator space houses 13 early-stage life science firms.

“There are numerous challenges when starting a company in the life sciences, but two of the first are finding funding and a home,” Philip Strandwitz, CEO and co-founder of Holobiome, said in a statement. “Fortunately, Alexandria is an unparalleled and best-in-class purveyor of both, and with their LaunchLabs and Seed Capital platforms, they provide a unique ecosystem and highly curated support that entrepreneurs and innovations need to thrive.”

Alexandria also has begun accepting applications for a pair of $125,000 innovation prizes, one open to Massachusetts-based life science researchers, and the other for academic spinouts nominated by university tech transfer offices. Nominations are due May 31 with selections scheduled in June. The recipients will receive $100,000 and one year of lab-office occupancy at Cambridge LaunchLabs.